Use Case

Randomized controlled trials

Run interventional studies with digital biomarkers—site-based or fully decentralized. Protocols, randomization, electronic consent, and three-portal infrastructure (participant app, healthcare worker portal, admin panel) all in one platform.

Study Protocol Dashboard
Active
Intervention
156 enrolled
94% protocol adherence
Control
144 enrolled
92% protocol adherence
Protocol Milestones
Baseline visit: 300/300
Week 12 follow-up: 287/300
Week 24 follow-up: On track

Three portals, one platform

Purpose-built interfaces for participants, healthcare workers, and research admins

📱

Participant App

Electronic consent, daily surveys, device pairing, and progress tracking—shipped to homes or used at sites

Electronic consent (eConsent)
Daily task checklist
Device sync status
Survey completion
Milestone tracking
🏥

Site Coordinator Portal

Real-time monitoring, protocol compliance alerts, visit scheduling, and adverse event reporting

Real-time participant dashboard
Protocol compliance alerts
Visit scheduling
Biomarker review
Adverse event reporting
📊

Admin Panel

Protocol management, randomization, enrollment tracking, data exports, and regulatory audit logs

Protocol configuration
Randomization engine
Enrollment metrics
Export for analysis
Regulatory audit logs

Site-based or fully remote

Run traditional site-based trials with clinic visits and lab draws. Or go fully decentralized with devices shipped to homes and virtual check-ins. Mix both models in a hybrid design. Same platform, flexible deployment.

Site-based trials
Clinic visits, in-person assessments, lab integration
Decentralized (DCT)
Nationwide recruitment, devices to homes, virtual visits
Hybrid models
Remote monitoring between quarterly clinic visits
Site-based
Recruitment
3-6 cities
Cost per participant
$20k/pt
Data collection
Quarterly visits
Decentralized
Recruitment
Nationwide
Cost per participant
$8k/pt
Data collection
Continuous

Streamlined enrollment

Electronic consent with eSignature. Automated eligibility screening. Device pairing with guided setup. Protocol training videos. Get participants enrolled and collecting data in one session.

1
Electronic consent (eConsent)
IRB-approved forms with e-signatures
2
Eligibility screening
Automated inclusion/exclusion criteria
3
Device pairing
CGM, wearables, scales—guided setup
4
Protocol training
Video walkthrough of study procedures
Enrollment Pipeline
Screening
412
In progress
Consent signed
324
Complete
Randomized
312
Complete
Devices paired
308
Complete
Baseline complete
300
Ready for protocol
Protocol Adherence Dashboard
CGM wear time
94%
Target: ≥70%On track
Daily surveys
89%
Target: ≥80%On track
Device sync
72%
Target: ≥85%Flagged
Visit attendance
97%
Target: ≥95%Excellent
Updated every 5 minutes

Automated protocol monitoring

Track protocol adherence in real-time. Automated alerts when participants fall below compliance thresholds. Coordinators intervene early before dropout. DSMB reviews live safety data, not quarterly reports.

Automated compliance checks
Protocol adherence calculated hourly
Early dropout prediction
ML alerts when participants drift off protocol
Device sync monitoring
Flag participants with offline devices
Live safety surveillance
DSMB dashboards with continuous updates

Ready to unify your digital biomarkers?

See how HealthGen can help you ship faster, scale further, and get to insights without rebuilding the stack.

Book a demoExplore the platform